Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction.

Int J Cardiol

UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.

Published: January 2016

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ijcard.2015.08.204	DOI Listing

Publication Analysis

efficacy safety

safety prognostic

prognostic benefit

benefit intravenous

intravenous iron

iron therapy

therapy ferric

ferric carboxymaltose

carboxymaltose patients

patients heart

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!